Alere, InDevR Win BARDA Contracts To Develop Rapid Influenza Tests
This article was originally published in The Gray Sheet
Executive Summary
Two rapid test manufacturers, Alere and InDevR, win multi-million dollar, multiple-year contracts with HHS’s Biomedical Advanced Research and Development Authority to develop point-of-care diagnostics to swiftly identify pandemic influenza strains from nasal samples.